Artificial Intelligence developed in New Zealand will soon to soon be used to screen thousands of patients in the early stages of melanoma Developed by the melanoma diagnostic service MoleMap, it is hoped the AI will help address a chronic shortage of dermatologist and skin cancer doctors in New Zealand. Joining Karyn to discuss the technology is MoleMap medical director Dr Franz Strydom